Search clinical trials for: early relapsing multiple sclerosis
Total 24258 results
-
Fondazione Don Carlo Gnocchi OnlusUppsala University; Sheba Medical Center; Careggi HospitalRecruitingMultiple Sclerosis, Relapsing-RemittingItaly
-
Novartis PharmaceuticalsRecruitingRelapsing Multiple SclerosisAustria
-
Johns Hopkins UniversityPatient-Centered Outcomes Research Institute; National Multiple Sclerosis SocietyRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapse Remitting Multiple SclerosisUnited States, Puerto Rico
-
The Cleveland ClinicUniversity of NottinghamActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom
-
BiogenCompletedRelapsing Remitting Multiple SclerosisPortugal
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, United Kingdom, Australia, Belgium, Brazil, Croatia, France, Canada, Slovakia, Germany, Netherlands, Norway, Italy, Poland, Switzerland, Romania, Bulgaria, Spain, Mexico, Austria, Portugal, Turkey, Sweden, Argentina, Denmark and more
-
Rennes University HospitalUnknown
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisSpain, Australia
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisCanada
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Russian Federation, Poland, Croatia, United Kingdom
-
BayerWithdrawnMultiple Sclerosis, Relapsing-RemittingKorea, Republic of
-
BayerCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Amphia HospitalSanofi; TEVA PharmachemieUnknown
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
Rennes University HospitalWyeth is now a wholly owned subsidiary of Pfizer; Bayer; Farmades, ItalyTerminatedRelapsing-Remitting Multiple SclerosisFrance, Italy
-
CelgeneNot yet recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Bristol-Myers SquibbNot yet recruitingRelapsing Multiple SclerosisChina
-
Shirley Ryan AbilityLabNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveUnited States
-
Technical University of MunichNot yet recruitingMultiple Sclerosis, Relapsing-Remitting | Optic Neuritis
-
SanofiRecruitingRelapsing Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisChina, Turkey, Korea, Republic of, United States, Ukraine
-
Novartis PharmaceuticalsNot yet recruitingMultiple Sclerosis, Relapsing-Remitting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMultiple Sclerosis | Remitting Relapsing Multiple SclerosisFrance
-
University of PaviaIRCCS National Neurological Institute "C. Mondino" Foundation; National Research...Not yet recruitingMultiple Sclerosis, Relapsing-Remitting | Environmental Exposure | Lifestyle FactorsItaly
-
Dent Neuroscience Research CenterGenentech, Inc., a subsidiary of F. Hoffman-La Roche AG; Monogram Biosciences...Not yet recruitingMultiple Sclerosis | Relapsing Remitting Multiple Sclerosis
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis-Relapsing-RemittingUnited States
-
Novartis PharmaceuticalsRecruiting
-
RenJi HospitalAbelZeta Pharma Inc.RecruitingA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy (CAR-AID)Systemic Lupus Erythematosus (SLE) | Neuromyelitis Optica Spectrum Disorders | Immune-Mediated Necrotizing Myopathy | Multiple Sclerosis-Relapsing-RemittingChina
-
Eli Lilly and CompanyRecruitingMultiple SclerosisUnited States, Poland, Germany, Italy, France, Israel, Latvia, Lithuania, Slovakia, United Kingdom
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Celgene CorporationRecruitingMultiple SclerosisUnited States, Belgium, France, Germany, Spain, United Kingdom, Italy
-
New York Stem Cell Foundation Research InstituteRecruitingPTSD | Multiple Sclerosis | Cervical Cancer | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes | Macular Degeneration | Diabetes Mellitus, Type 1 | Parkinson Disease | Amyotrophic Lateral Sclerosis | Dementia | Ovarian Cancer | Alzheimer Disease | ALS | Vulvar Cancer | Post Traumatic Stress Disorder | Lewy Body Disease and other conditionsUnited States
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of Sheffield; Nottingham Trent University; Sheffield Hospitals CharityRecruiting
-
University of AarhusAarhus University Hospital; Regionshospitalet Viborg, Skive; Gødstrup Hospital; Sorbonne UniversityRecruitingRelapsing Remitting Multiple SclerosisDenmark
-
TG Therapeutics, Inc.RecruitingA Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk (PROVIDE)Relapsing Multiple SclerosisUnited States
-
SanofiRecruitingMultiple SclerosisUnited States, Canada, Puerto Rico, United Kingdom
-
Stanford UniversityKyverna TherapeuticsRecruitingMultiple Sclerosis | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Ataturk UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingTurkey
-
University Hospital, Basel, SwitzerlandRecruitingMultiple Sclerosis, Relapsing-RemittingSwitzerland
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
Amsterdam UMC, location VUmcGenzyme, a Sanofi Company; Universiteit Leiden; Personal Fitness Nederland; MS... and other collaboratorsRecruitingMultiple SclerosisNetherlands
-
Cionic, Inc.RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-RemittingUnited States
-
University Hospital, MontpellierRecruiting
-
The University of Texas at DallasUniversity of Texas Southwestern Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Hoffmann-La RocheicometrixNot yet recruitingRelapsing Remitting Multiple Sclerosis
-
Brugmann University HospitalRecruitingMultiple SclerosisBelgium
-
Universität MünsterRecruitingMultiple Sclerosis, Relapsing-RemittingGermany
-
CelltrionNot yet recruitingRelapsing-remitting Multiple Sclerosis
-
TG Therapeutics, Inc.RecruitingRelapsing Multiple SclerosisUnited States